The Food and Drug Administration has approved two human clinical trials for the drug.
Positive cases, hospitalizations and deaths are on the rise. Texas A&M infectious disease experts discuss the direction of the pandemic.
The unique interagency agreement between Texas A&M and the Brazos County Health District aims to contain COVID-19 transmission on campus.
The virus' similitaries have caused some to underestimate the illness caused by the novel coronavirus. A Texas A&M clinical assistant professor explains how COVID-19 differs from the flu.
A Texas A&M socilogist discusses how incarcerated populations are put at risk during the pandemic response.
Volunteers across the state will make face masks for hospitals, clinics and medical facilities to protect against the deadly virus.
Professor Wenshe Ray Liu was the first to ID the drug as a possible treatment for COVID-19.
Agency responders are pitching in at staging areas throughout the state.
Research teams are invited to compete for grants for research related to the pandemic.
A team from the SuSu and Mark A. Fischer ’72 Engineering Design Center are working to make 3,000 shields to protect medical workers.
A Texas A&M professor discusses how the pandemic is changing the way people worship.
Texas A&M AgriLife Extension Service experts explain some of the time-tested self-suffiency practices people have been turning to during the pandemic.
With no drug approved for treating the illness, the College of Dentistry's Jayne S. Reuben explains what's known about how to address symptoms.
